| UniProt ID | RBM45_HUMAN | |
|---|---|---|
| UniProt AC | Q8IUH3 | |
| Protein Name | RNA-binding protein 45 | |
| Gene Name | RBM45 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 476 | |
| Subcellular Localization | Cytoplasm . Nucleus . Predominantly cytoplasmic. May shuttle between cytoplasm and nucleus. | |
| Protein Description | RNA-binding protein with binding specificity for poly(C). May play an important role in neural development.. | |
| Protein Sequence | MDEAGSSASGGGFRPGVDSLDEPPNSRIFLVISKYTPESVLRERFSPFGDIQDIWVVRDKHTKESKGIAFVKFARSSQACRAMEEMHGQCLGPNDTKPIKVFIAQSRSSGSHRDVEDEELTRIFVMIPKSYTEEDLREKFKVYGDIEYCSIIKNKVTGESKGLGYVRYLKPSQAAQAIENCDRSFRAILAEPKNKASESSEQDYYSNMRQEALGHEPRVNMFPFVGEQQSEFSSFDKNDSRGQEAISKRLSVVSRVPFTEEQLFSIFDIVPGLEYCEVQRDPYSNYGHGVVQYFNVASAIYAKYKLHGFQYPPGNRIGVSFIDDGSNATDLLRKMATQMVAAQLASMVWNNPSQQQFMQFGGSSGSQLPQIQTDVVLPSCKKKAPAETPVKERLFIVFNPHPLPLDVLEDIFCRFGNLIEVYLVSGKNVGYAKYADRISANDAIATLHGKILNGVRLKVMLADSPREESNKRQRTY | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 6 | Phosphorylation | --MDEAGSSASGGGF --CCCCCCCCCCCCC | 29.76 | 27251275 | |
| 7 | Phosphorylation | -MDEAGSSASGGGFR -CCCCCCCCCCCCCC | 26.07 | 27251275 | |
| 9 | Phosphorylation | DEAGSSASGGGFRPG CCCCCCCCCCCCCCC | 39.66 | 28348404 | |
| 34 | Sumoylation | RIFLVISKYTPESVL EEEEEEECCCCHHHH | 41.86 | 28112733 | |
| 46 | Phosphorylation | SVLRERFSPFGDIQD HHHHHCCCCCCCCEE | 26.07 | 20068231 | |
| 97 | Acetylation | CLGPNDTKPIKVFIA CCCCCCCCCEEEEEE | 47.83 | 27452117 | |
| 143 | Phosphorylation | LREKFKVYGDIEYCS HHHHCEEECCEEEEE | 15.07 | - | |
| 150 | Phosphorylation | YGDIEYCSIIKNKVT ECCEEEEEEEECCCC | 26.84 | 24719451 | |
| 153 | Acetylation | IEYCSIIKNKVTGES EEEEEEEECCCCCCC | 49.39 | 26051181 | |
| 161 | Acetylation | NKVTGESKGLGYVRY CCCCCCCCCCCCEEE | 54.58 | 7965505 | |
| 161 | Ubiquitination | NKVTGESKGLGYVRY CCCCCCCCCCCCEEE | 54.58 | 29967540 | |
| 165 | Phosphorylation | GESKGLGYVRYLKPS CCCCCCCCEEEECHH | 6.18 | - | |
| 170 (in isoform 3) | Ubiquitination | - | 33.42 | - | |
| 170 | Ubiquitination | LGYVRYLKPSQAAQA CCCEEEECHHHHHHH | 33.42 | 29967540 | |
| 184 | Phosphorylation | AIENCDRSFRAILAE HHHHCCHHHHHHHCC | 13.06 | 30576142 | |
| 193 | Ubiquitination | RAILAEPKNKASESS HHHHCCCCCCCCCCC | 63.69 | 29967540 | |
| 199 | Phosphorylation | PKNKASESSEQDYYS CCCCCCCCCHHHHHH | 36.36 | 30576142 | |
| 200 | Phosphorylation | KNKASESSEQDYYSN CCCCCCCCHHHHHHH | 34.91 | 27251275 | |
| 204 | Phosphorylation | SESSEQDYYSNMRQE CCCCHHHHHHHHHHH | 14.42 | 27642862 | |
| 205 | Phosphorylation | ESSEQDYYSNMRQEA CCCHHHHHHHHHHHH | 11.23 | 27642862 | |
| 228 (in isoform 2) | Phosphorylation | - | 46.28 | 21406692 | |
| 228 (in isoform 3) | Phosphorylation | - | 46.28 | 21406692 | |
| 231 (in isoform 2) | Phosphorylation | - | 45.25 | 21406692 | |
| 231 (in isoform 3) | Phosphorylation | - | 45.25 | 21406692 | |
| 232 (in isoform 2) | Phosphorylation | - | 10.05 | 21406692 | |
| 232 (in isoform 3) | Phosphorylation | - | 10.05 | 21406692 | |
| 235 | Ubiquitination | QQSEFSSFDKNDSRG CHHHCCCCCCCCCHH | 17.55 | 29967540 | |
| 235 (in isoform 2) | Ubiquitination | - | 17.55 | 21906983 | |
| 235 (in isoform 3) | Ubiquitination | - | 17.55 | 21906983 | |
| 237 | Ubiquitination | SEFSSFDKNDSRGQE HHCCCCCCCCCHHHH | 61.72 | - | |
| 240 | Phosphorylation | SSFDKNDSRGQEAIS CCCCCCCCHHHHHHH | 47.94 | 29978859 | |
| 388 | Phosphorylation | KKKAPAETPVKERLF CCCCCCCCCCCEEEE | 35.17 | 28555341 | |
| 422 | Phosphorylation | FGNLIEVYLVSGKNV HCCEEEEEEECCCCC | 6.65 | 17053785 | |
| 431 | Phosphorylation | VSGKNVGYAKYADRI ECCCCCCHHHHHHHC | 8.81 | 17053785 | |
| 431 | Ubiquitination | VSGKNVGYAKYADRI ECCCCCCHHHHHHHC | 8.81 | 29967540 | |
| 434 | Phosphorylation | KNVGYAKYADRISAN CCCCHHHHHHHCCCC | 12.93 | 17053785 | |
| 439 | Phosphorylation | AKYADRISANDAIAT HHHHHHCCCCHHHHH | 23.16 | - | |
| 462 | Phosphorylation | VRLKVMLADSPREES CEEEEEECCCCCHHH | 9.35 | 18691976 | |
| 464 | Phosphorylation | LKVMLADSPREESNK EEEEECCCCCHHHHC | 21.90 | 30266825 | |
| 469 | Phosphorylation | ADSPREESNKRQRTY CCCCCHHHHCCCCCC | 42.79 | 23186163 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RBM45_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RBM45_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RBM45_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| RBM45_HUMAN | RBM45 | physical | 25416956 | |
| ECT2_HUMAN | ECT2 | physical | 26496610 | |
| KIF22_HUMAN | KIF22 | physical | 26496610 | |
| PPM1G_HUMAN | PPM1G | physical | 26496610 | |
| ATPK_HUMAN | ATP5J2 | physical | 26496610 | |
| AFG32_HUMAN | AFG3L2 | physical | 26496610 | |
| FND3A_HUMAN | FNDC3A | physical | 26496610 | |
| PUM2_HUMAN | PUM2 | physical | 26496610 | |
| CTBL1_HUMAN | CTNNBL1 | physical | 26496610 | |
| DOT1L_HUMAN | DOT1L | physical | 26496610 | |
| RUSD4_HUMAN | RPUSD4 | physical | 26496610 | |
| K2013_HUMAN | KIAA2013 | physical | 26496610 | |
| KMT2D_HUMAN | KMT2D | physical | 26496610 | |
| KEAP1_HUMAN | KEAP1 | physical | 25939382 | |
| NF2L2_HUMAN | NFE2L2 | physical | 25939382 | |
| SQSTM_HUMAN | SQSTM1 | physical | 25939382 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-464, AND MASSSPECTROMETRY. | |
| "Tyrosine phosphorylated Par3 regulates epithelial tight junctionassembly promoted by EGFR signaling."; Wang Y., Du D., Fang L., Yang G., Zhang C., Zeng R., Ullrich A.,Lottspeich F., Chen Z.; EMBO J. 25:5058-5070(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-422; TYR-431 ANDTYR-434, AND MASS SPECTROMETRY. | |